Home/Filings/4/0001209191-22-061044
4//SEC Filing

Lam Jennifer 4

Accession 0001209191-22-061044

CIK 0001637715other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 6:13 PM ET

Size

6.4 KB

Accession

0001209191-22-061044

Insider Transaction Report

Form 4
Period: 2022-12-09
Lam Jennifer
VP of Finance & Administration
Transactions
  • Award

    Stock option (right to buy)

    2022-12-09+90,00090,000 total
    Exercise: $1.80Exp: 2032-12-08Common Stock (90,000 underlying)
Holdings
  • Common Stock

    20,600
Footnotes (2)
  • [F1]Includes 1,600 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan (the "Plan") on June 8, 2022 and 4,000 shares acquired under the Plan on December 8, 2022.
  • [F2]The shares vest in a series of equal quarterly installments measured from December 9, 2022 subject to Reporting Person's Continuous Service (as defined in the Issuer's 2021 Equity Incentive Plan) as of each such vesting date.

Issuer

Reneo Pharmaceuticals, Inc.

CIK 0001637715

Entity typeother

Related Parties

1
  • filerCIK 0001919598

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 6:13 PM ET
Size
6.4 KB